APA (7th ed.) Citation

J, Y., L, C., SS, Z., C, D., YZ, F., HX, L., . . . YZ, L. (2024). FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate. Frontiers in pharmacology, 15, 1422770. https://doi.org/10.3389/fphar.2024.1422770

Chicago Style (17th ed.) Citation

J, Yang, Chen L, Zhao SS, Du C, Fan YZ, Liu HX, Li Y, and Li YZ. "FGF21-dependent Alleviation of Cholestasis-induced Liver Fibrosis by Sodium Butyrate." Frontiers in Pharmacology 15 (2024): 1422770. https://doi.org/10.3389/fphar.2024.1422770.

MLA (9th ed.) Citation

J, Yang, et al. "FGF21-dependent Alleviation of Cholestasis-induced Liver Fibrosis by Sodium Butyrate." Frontiers in Pharmacology, vol. 15, 2024, p. 1422770, https://doi.org/10.3389/fphar.2024.1422770.